TMDX Stock Price
TransMedics Group, Inc.
TMDX stock price is $70.78 (-7.50% on the day), giving TransMedics Group, Inc. a market cap of $2.45B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
TMDX Stock Overview
- Price
- $70.78
- Previous close
- $76.52
- Open
- $76.52
- Market cap
- $2.45B
- P/E ratio
- 12.9
- 52-week range
- $60.10 - $156.00
- 1-year price target
- $97.25
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NSD
- MarketXLS Rank
- 51
About TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TMDX | $70.78 | -7.5% | 1.07M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |